Neogenomics Inc
SWB:NG9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neogenomics Inc
SWB:NG9
|
US |
|
N
|
Nippon Telegraph and Telephone Corp
F:NTT
|
JP |
|
S
|
SBI Holdings Inc
SWB:ZOF
|
JP |
|
Ocado Group PLC
F:0OC1
|
UK |
|
Compagnie De l'odet SE
F:49F
|
FR |
|
P
|
Patterson Companies Inc
SWB:PD2
|
US |
|
TomTom NV
F:OEMB
|
NL |
|
Inchcape PLC
LSE:INCH
|
UK |
|
Y
|
Yoc AG
SWB:YOC
|
DE |
|
Haypp Group AB (publ)
F:8QG0
|
SE |
|
Link Mobility Group Holding ASA
OTC:LMGHF
|
NO |
|
E
|
Emmi AG
XBER:FV6
|
CH |
Wall St Price Targets
NG9 Price Targets Summary
Neogenomics Inc
According to Wall Street analysts, the average 1-year price target for NG9 is 13.24 EUR with a low forecast of 9.58 EUR and a high forecast of 22.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NG9's stock price target?
Price Target
13.24
EUR
According to Wall Street analysts, the average 1-year price target for NG9 is 13.24 EUR with a low forecast of 9.58 EUR and a high forecast of 22.63 EUR.
What is the Revenue forecast for Neogenomics Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Neogenomics Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 5 years is 12%.
